ProShare Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $758K | Sell |
7,109
-276,032
| -97% | -$33.4M | ﹤0.01% | 889 |
|
|
2026
Q1 | $46.3M | Sell |
283,141
-57,599
| -17% | -$8.86M | 0.07% | 169 |
|
|
2025
Q4 | $59.3M | Buy |
340,740
+333,210
| +4,425% | +$60.8M | 0.1% | 170 |
|
|
2025
Q3 | $1.08M | Buy |
7,530
+729
| +11% | +$89.3K | ﹤0.01% | 789 |
|
|
2025
Q2 | $684K | Sell |
6,801
-38,688
| -85% | -$2.96M | ﹤0.01% | 957 |
|
|
2025
Q1 | $3.47M | Sell |
45,489
-11,502
| -20% | -$880K | 0.01% | 584 |
|
|
2024
Q4 | $3.93M | Buy |
56,991
+17,141
| +43% | +$1.23M | 0.01% | 556 |
|
|
2024
Q3 | $2.91M | Buy |
39,850
+9,710
| +32% | +$717K | 0.01% | 621 |
|
|
2024
Q2 | $2.02M | Sell |
30,140
-5,101
| -14% | -$198K | 0.01% | 669 |
|
|
2024
Q1 | $956K | Buy |
35,241
+3,218
| +10% | +$90.1K | ﹤0.01% | 799 |
|
|
2023
Q4 | $992K | Buy |
32,023
+5,498
| +21% | +$143K | ﹤0.01% | 756 |
|
|
2023
Q3 | $670K | Buy |
26,525
+552
| +2% | +$12.6K | ﹤0.01% | 808 |
|
|
2023
Q2 | $548K | Buy |
25,973
+606
| +2% | +$11.5K | ﹤0.01% | 907 |
|
|
2023
Q1 | $433K | Sell |
25,367
-3,232
| -11% | -$62.8K | ﹤0.01% | 974 |
|
|
2022
Q4 | $571K | Buy |
28,599
+5,360
| +23% | +$104K | ﹤0.01% | 902 |
|
|
2022
Q3 | $500K | Buy |
23,239
+534
| +2% | +$12.8K | ﹤0.01% | 896 |
|
|
2022
Q2 | $448K | Sell |
22,705
-11,748
| -34% | -$246K | ﹤0.01% | 986 |
|
|
2022
Q1 | $809K | Sell |
34,453
-8,015
| -19% | -$186K | ﹤0.01% | 1007 |
|
|
2021
Q4 | $1.16M | Buy |
42,468
+3,114
| +8% | +$89K | ﹤0.01% | 956 |
|
|
2021
Q3 | $1.08M | Sell |
39,354
-8,095
| -17% | -$212K | ﹤0.01% | 882 |
|
|
2021
Q2 | $1.35M | Buy |
47,449
+6,142
| +15% | +$182K | ﹤0.01% | 871 |
|
|
2021
Q1 | $1.41M | Buy |
41,307
+3,159
| +8% | +$121K | ﹤0.01% | 822 |
|
|
2020
Q4 | $1.27M | Buy |
38,148
+9,386
| +33% | +$343K | ﹤0.01% | 786 |
|
|
2020
Q3 | $924K | Sell |
28,762
-1,143
| -4% | -$32.9K | ﹤0.01% | 744 |
|
|
2020
Q2 | $824K | Buy |
29,905
+12,401
| +71% | +$294K | ﹤0.01% | 770 |
|
|
2020
Q1 | $281K | Sell |
17,504
-13,879
| -44% | -$329K | ﹤0.01% | 899 |
|
|
2019
Q4 | $749K | Sell |
31,383
-2,907
| -8% | -$59.1K | ﹤0.01% | 904 |
|
|
2019
Q3 | $605K | Buy |
34,290
+636
| +2% | +$12.3K | ﹤0.01% | 916 |
|
|
2019
Q2 | $862K | Sell |
33,654
-1,013
| -3% | -$28.2K | 0.01% | 811 |
|
|
2019
Q1 | $1.01M | Buy |
34,667
+514
| +2% | +$13.3K | 0.01% | 756 |
|
|
2018
Q4 | $448K | Sell |
34,153
-6,632
| -16% | -$106K | ﹤0.01% | 988 |
|
|
2018
Q3 | $825K | Sell |
40,785
-1,504
| -4% | -$34K | 0.01% | 903 |
|
|
2018
Q2 | $1M | Sell |
42,289
-2,918
| -6% | -$75.1K | 0.01% | 833 |
|
|
2018
Q1 | $1.02M | Sell |
45,207
-7,413
| -14% | -$195K | 0.01% | 809 |
|
|
2017
Q4 | $1.64M | Buy |
52,620
+12,381
| +31% | +$366K | 0.01% | 666 |
|
|
2017
Q3 | $1.26M | Buy |
40,239
+2,847
| +8% | +$54.2K | 0.01% | 681 |
|
|
2017
Q2 | $642K | Sell |
37,392
-2,840
| -7% | -$48.5K | 0.01% | 870 |
|
|
2017
Q1 | $704K | Sell |
40,232
-10,594
| -21% | -$163K | 0.01% | 883 |
|
|
2016
Q4 | $672K | Buy |
50,826
+5,683
| +13% | +$77.5K | 0.01% | 946 |
|
|
2016
Q3 | $655K | Sell |
45,143
-8,492
| -16% | -$106K | 0.01% | 836 |
|
|
2016
Q2 | $529K | Buy |
53,635
+316
| +0.6% | +$3.69K | 0.01% | 945 |
|
|
2016
Q1 | $676K | Sell |
53,319
-5,337
| -9% | -$70.2K | 0.01% | 871 |
|
|
2015
Q4 | $1.06M | Buy |
58,656
+5,686
| +11% | +$100K | 0.01% | 706 |
|
|
2015
Q3 | $984K | Sell |
52,970
-3,933
| -7% | -$98.2K | 0.01% | 675 |
|
|
2015
Q2 | $1.39M | Buy |
56,903
+7,053
| +14% | +$160K | 0.02% | 635 |
|
|
2015
Q1 | $1.04M | Buy |
49,850
+6,323
| +15% | +$111K | 0.01% | 828 |
|
|
2014
Q4 | $673K | Buy |
43,527
+23,858
| +121% | +$339K | 0.01% | 1064 |
|
|
2014
Q3 | $257K | Buy |
19,669
+531
| +3% | +$8.01K | ﹤0.01% | 1817 |
|
|
2014
Q2 | $382K | Sell |
19,138
-15,894
| -45% | -$235K | ﹤0.01% | 1757 |
|
|
2014
Q1 | $667K | Buy |
+35,032
| New | +$666K | 0.01% | 1632 |
|
|
2013
Q4 | – | Sell |
-21,853
| Closed | -$341K | – | 1596 |
|
|
2013
Q3 | $341K | Buy |
+21,853
| New | +$278K | 0.01% | 1793 |
|
Other funds holding INSM
BBA
DGM
OAG
ProShare Advisors's INSM Position: Q2 2026 in Review
ProShare Advisors reduced its Insmed (INSM) stake by 97% in Q2 2026, selling an estimated $33.4M and leaving 7,109 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #889.
ProShare Advisors first reported a position in INSM in Q3 2013 and has held it in 51 quarters since. The position peaked at $59.3M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- ProShare Advisors held 7,109 shares of Insmed worth $758K as of Q2 2026.
- ProShare Advisors sold 276,032 Insmed shares in Q2 2026, an estimated $33.4M.
- Insmed made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #889 holding.
- ProShare Advisors first reported a position in Insmed in Q3 2013 and has held it in 51 quarters since.
- ProShare Advisors's Insmed position peaked at $59.3M in Q4 2025.
- 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.